Stay Up
to Date
Stay Up
to Date
Breaking News,
Updates, & More
Breaking News,
Updates, & More
Click Here to
Subscribe
Click Here to
Subscribe

Hematologic Cancers

  • Xospata Extends Overall Survival in Patients with FLT3 Mutation–Positive Relapsed or Refractory Acute Myeloid Leukemia
  • Published Results from KEYNOTE-048 Trial Show Extended Survival with Keytruda in Advanced Head and Neck Cancers
  • Discussing Costs of Genomic Testing with Patients

According to the review of approximately 300,000 patients by Sikander Ailawadhi, MD, Oncologist, Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL, and colleagues, there was also significant heterogeneity in practice patterns across all characteristics studied.

Leslie Lauersdorf insist that it's vital to inform your patients about what's involved in beginning daratumumab treatments, especially because of the lengthy chair time.
Tiffany Richards insists on the importance of survivorship care in patients with multiple myeloma and explains how to make sure patients stay as healthy as possible for as long as possible.
Tiffany Richards is excited about all the new multiple myeloma treatments that are being introduced, but understands that the question of how to best utilize these drugs still remains to be answered.
Tiffany Richards stresses the importance of educating patients about side effects and what to do when these side effects begin to present.
Tiffany Richards shares anecdotes that illustrate why it's important to really know your patients in order to effectively care for them.
Tiffany Richards discusses the numerous, often unmet, needs of patients with multiple myeloma.
Tiffany Richards provides an overview of the most common questions she hears from patients regarding daratumumab.
Tiffany Richards expresses her positive outlook on daratumumab, citing that the treatment has helped extend life expentancies.
Page 1 of 11
Results 1 - 10 of 102